This OS is in agreement with the median OS of IgD MM patients after autologous SCT (30 months [6]) but is lower than the median OS reported for patients with FLC escape after IgG or IgA MM (47.5 months [2]). The gene discussed is CD79A; the disease is Miyoshi myopathy.